- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有293家主力机构披露2026-06-30报告期持股数据，持仓量总计4723.13万股，占流通A股20.22%
- 波段诊断：
-
技术面诊股
诊断结果：8.0技术面打败了94%的股票
技术面评分前10的股票
近期的平均成本为45.07元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为45.07元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"45.07","date":1794384681,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2026.11.12","stock":"-1.22","trade":null,"ind":"-1.68"},{"date":"2026.11.11","stock":"-2.14","trade":null,"ind":"1.32"},{"date":"2026.11.10","stock":"-1.99","trade":null,"ind":"0.86"},{"date":"2026.11.09","stock":"-2.26","trade":null,"ind":"-0.27"},{"date":"2026.11.06","stock":"-2.90","trade":null,"ind":"-2.57"},{"date":"2026.11.05","stock":"20.00","trade":null,"ind":"1.19"},{"date":"2026.11.04","stock":"6.75","trade":null,"ind":"4.22"},{"date":"2026.11.03","stock":"-5.87","trade":null,"ind":"-1.21"},{"date":"2026.11.02","stock":"8.43","trade":null,"ind":"1.63"},{"date":"2026.10.30","stock":"-2.28","trade":null,"ind":"-2.73"},{"date":"2026.10.29","stock":"0.39","trade":null,"ind":"-2.92"},{"date":"2026.10.28","stock":"5.31","trade":null,"ind":"2.02"},{"date":"2026.10.27","stock":"-5.90","trade":null,"ind":"-2.50"},{"date":"2026.10.26","stock":"-0.10","trade":null,"ind":"-1.19"},{"date":"2026.10.23","stock":"0.96","trade":null,"ind":"2.79"},{"date":"2026.10.22","stock":"-4.04","trade":null,"ind":"-2.96"},{"date":"2026.10.21","stock":"0.96","trade":null,"ind":"-0.82"},{"date":"2026.10.20","stock":"1.74","trade":null,"ind":"-0.14"},{"date":"2026.10.19","stock":"4.36","trade":null,"ind":"0.13"},{"date":"2026.10.16","stock":"0.46","trade":null,"ind":"-0.12"},{"date":"2026.10.15","stock":"-4.29","trade":null,"ind":"-2.43"}]
福瑞医科,深证成指,医疗器械指数
压力支撑
该股压力位为45.06元，支撑位为44.00元。
[{"text":"\u538b\u529b\u4f4d","value":"45.06","date":1794412800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"44.00","date":1794412800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了18%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月12日 20:30
| 机构今日流向(万元) | -1013.58 | 机构5日流向(万元) | -2453.80 |
| 机构10日流向(万元) | 535.12 | 机构20日流向(万元) | 3659.04 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少343.2万股，其中基金净增仓33家，主力净增仓78家，请投资者中长期谨慎为宜。
截止2026-06-30，共293家主力机构（基金289家，一般法人3家，阳光私募1家），持仓量总计4723.13万股，占流通A股20.22%
其中，基金持仓与2025-12-31相比：
增仓：61家 ，增持 394.21万股
减仓：28家 ，减持 508.48万股
新出现在主力名单中：196家 ，持有774.81万股
从主力名单中消失：118家 ，原持有1275.11万股
其中，基金持仓与2025-12-31相比：
增仓：61家 ，增持 394.21万股
减仓：28家 ，减持 508.48万股
新出现在主力名单中：196家 ，持有774.81万股
从主力名单中消失：118家 ，原持有1275.11万股
消息面诊股
诊断结果：5.5消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 福瑞医科：11月11日获融资买入2927.77万元
2026-11-12 - 概念动态|福瑞医科新增“机器人概念”
2026-11-11 - 券商观点|医药生物周报：26Q3基金占比提升，资金
2026-11-11 - 福瑞医科：11月10日获融资买入3518.79万元
2026-11-11 - 福瑞医科：11月9日获融资买入6360.61万元
2026-11-10 - 券商观点|医药行业周报：Echosens股权整合与
2026-11-09 - 福瑞医科：11月6日获融资买入8005.29万元
2026-11-09 - 福瑞医科参股公司SONOVEIN 获FDA De
2026-11-06 - 福瑞医科获多家机构调研：联合收购实现实控人与公司长
2026-11-06 - 不用开刀、不用导管，全球首个无创静脉曲张设备获FD
2026-11-06
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-11-03 |
| 一般消息 | 重大事项 | 关联交易 | 2026-11-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-25 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2026-03-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-25 |
| 利好 | 业绩预告 | 业绩预增 | 2026-01-23 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-01-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-11 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-10 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：3.5行业面打败了22%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.11.12","price":"-1.68","value":null},{"date":"2026.11.11","price":"1.32","value":null},{"date":"2026.11.10","price":"0.86","value":null},{"date":"2026.11.09","price":"-0.27","value":null},{"date":"2026.11.06","price":"-2.57","value":null},{"date":"2026.11.05","price":"1.19","value":null},{"date":"2026.11.04","price":"4.22","value":null},{"date":"2026.11.03","price":"-1.21","value":null},{"date":"2026.11.02","price":"1.63","value":null},{"date":"2026.10.30","price":"-2.73","value":null},{"date":"2026.10.29","price":"-2.92","value":null},{"date":"2026.10.28","price":"2.02","value":null},{"date":"2026.10.27","price":"-2.50","value":null},{"date":"2026.10.26","price":"-1.19","value":null},{"date":"2026.10.23","price":"2.79","value":null},{"date":"2026.10.22","price":"-2.96","value":null},{"date":"2026.10.21","price":"-0.82","value":null},{"date":"2026.10.20","price":"-0.14","value":null},{"date":"2026.10.19","price":"0.13","value":null},{"date":"2026.10.16","price":"-0.12","value":null},{"date":"2026.10.15","price":"-2.43","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 健帆生物 | 29.70% | -5.08% | 6.0分 |
| 2 | 戴维医疗 | 27.40% | 5.13% | 5.0分 |
| 3 | 山外山 | 24.08% | -1.19% | 5.2分 |
| 4 | 安图生物 | 19.85% | -4.43% | 5.7分 |
| 5 | 福瑞医科 | 19.12% | -10.08% | 6.0分 |
| 6 | 威高血净 | 17.70% | 0.88% | 6.4分 |
| 8 | 翔宇医疗 | 16.60% | 2.07% | 4.7分 |
| 10 | 美好医疗 | 11.07% | -0.35% | 6.0分 |
| 12 | 微电生理 | 10.94% | -3.59% | 4.7分 |
| 14 | 奕瑞科技 | 10.70% | 0.72% | 5.3分 |
| 16 | 澳华内镜 | 10.65% | -4.11% | 5.2分 |
| 18 | 九强生物 | 10.25% | -0.78% | 5.1分 |
| 20 | 康众科技 | 9.70% | 3.61% | 5.0分 |
| 22 | 天益医疗 | 9.41% | -0.67% | 5.4分 |
| 24 | 理邦仪器 | 8.52% | -3.66% | 5.3分 |
| 26 | 惠泰医疗 | 7.62% | -1.30% | 5.5分 |
| 28 | 迈瑞医疗 | 7.13% | -2.89% | 6.2分 |
| 30 | 九安医疗 | 6.53% | 4.19% | 5.3分 |
| 32 | 鱼跃医疗 | 6.03% | -6.72% | 4.9分 |
| 34 | 南微医学 | 5.28% | -6.18% | 5.3分 |
| 36 | 爱博医疗 | 5.16% | -5.69% | 4.7分 |
| 38 | 利德曼 | 4.59% | 0.99% | 5.7分 |
| 40 | 拱东医疗 | 4.23% | 0.40% | 4.9分 |
| 42 | 麦克奥迪 | 4.05% | -0.72% | 5.6分 |
| 44 | 祥生医疗 | 3.25% | -1.22% | 5.1分 |
| 46 | 东方生物 | 3.18% | 5.68% | 4.4分 |
| 48 | *ST海利 | 2.76% | -0.67% | 5.0分 |
| 50 | 天臣医疗 | 2.59% | 5.71% | 5.2分 |
| 52 | 春立医疗 | 1.92% | -3.99% | 4.8分 |
| 54 | 欧普康视 | 1.59% | -5.47% | 4.6分 |
| 56 | 健尔康 | 1.29% | -0.47% | 5.2分 |
| 58 | 洁特生物 | 1.16% | 7.58% | 4.5分 |
| 60 | 伟思医疗 | 0.91% | -1.25% | 4.7分 |
| 62 | 港通医疗 | 0.55% | 1.94% | 5.0分 |
| 64 | 浩欧博 | 0.21% | -3.39% | 4.9分 |
| 66 | 美康生物 | 0.10% | -0.30% | 4.7分 |
| 68 | 楚天科技 | 0.00% | -5.32% | 4.5分 |
| 70 | 中源协和 | 0.00% | -2.74% | 5.3分 |
| 72 | *ST明德 | -0.14% | -0.21% | 4.5分 |
| 74 | - | -0.29% | -1.42% | 分 |
| 76 | - | -0.89% | -2.95% | 分 |
| 78 | 英科医疗 | -1.24% | -4.68% | 5.0分 |
| 80 | 南卫股份 | -1.48% | -0.87% | 4.7分 |
| 82 | 海尔生物 | -1.81% | -5.40% | 5.3分 |
| 84 | 乐心股份 | -1.86% | 2.02% | 5.2分 |
| 86 | 华强科技 | -2.08% | -1.52% | 4.1分 |
| 88 | 睿昂基因 | -2.49% | 1.32% | 3.8分 |
| 90 | 昊海生科 | -2.65% | -3.97% | 4.8分 |
| 92 | - | -2.79% | -2.45% | 分 |
| 94 | 迈克生物 | -3.05% | -3.05% | 3.8分 |
| 96 | 宝莱特 | -3.29% | -3.72% | 5.1分 |
| 98 | 安旭生物 | -3.97% | -1.30% | 3.8分 |
| 100 | 康泰医学 | -4.11% | -3.92% | 4.0分 |
| 102 | 康为世纪 | -4.19% | 0.48% | 4.7分 |
| 104 | 可孚医疗 | -4.37% | -3.41% | 5.0分 |
| 106 | 西山科技 | -4.51% | -2.44% | 3.3分 |
| 108 | 凯普生物 | -4.87% | -4.55% | 3.4分 |
| 110 | 正川股份 | -5.12% | -5.18% | 4.1分 |
| 112 | - | -5.66% | -2.65% | 分 |
| 114 | 正海生物 | -5.97% | -1.89% | 4.6分 |
| 116 | 热景生物 | -6.48% | -1.77% | 4.5分 |
| 118 | 尚荣医疗 | -6.83% | -0.66% | 4.7分 |
| 120 | 达安基因 | -7.01% | -1.48% | 4.3分 |
| 122 | - | -7.15% | -2.30% | 分 |
| 124 | 易瑞生物 | -7.92% | -2.19% | 4.0分 |
| 126 | 基蛋生物 | -8.36% | -1.95% | 4.8分 |
| 128 | 力诺药包 | -9.11% | 1.22% | 5.2分 |
| 130 | 科华生物 | -10.43% | 0.58% | 4.7分 |
| 132 | 瑞迈特 | -11.99% | -2.26% | 4.9分 |
| 134 | 五洲医疗 | -13.43% | 14.06% | 4.7分 |
| 136 | 蓝帆医疗 | -15.67% | -4.02% | 5.1分 |
| 138 | - | -25.76% | -5.39% | 分 |
| 140 | 奥精医疗 | -55.53% | 2.69% | 3.6分 |
| 142 | - | - | 2.53% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/243 ， 10/243。
[{"date":"2026-09-30","value":"6.74","vol":"3.55"},{"date":"2026-06-30","value":"3.24","vol":"2.35"},{"date":"2026-03-31","value":"1.61","vol":"1.12"},{"date":"2025-12-31","value":"8.27","vol":"2.37"},{"date":"2025-09-30","value":"6.13","vol":"3.06"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.74 | 3.24 | 1.61 | 8.27 | 6.13 |
| 行业(%) | 3.55 | 2.35 | 1.12 | 2.37 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"75.67","vol":"52.26"},{"date":"2026-06-30","value":"75.76","vol":"52.38"},{"date":"2026-03-31","value":"74.89","vol":"52.12"},{"date":"2025-12-31","value":"74.97","vol":"51.82"},{"date":"2025-09-30","value":"75.26","vol":"52.03"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.67 | 75.76 | 74.89 | 74.97 | 75.26 |
| 行业(%) | 52.26 | 52.38 | 52.12 | 51.82 | 52.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 73/243 ， 36/243。
[{"date":"2026-09-30","value":"3.67","vol":"7.31"},{"date":"2026-06-30","value":"5.80","vol":"5.46"},{"date":"2026-03-31","value":"9.00","vol":"5.59"},{"date":"2025-12-31","value":"18.26","vol":"1.01"},{"date":"2025-09-30","value":"12.37","vol":"0.11"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
3.67 | 5.80 | 9.00 | 18.26 | 12.37 |
| 行业(%) | 7.31 | 5.46 | 5.59 | 1.01 | 0.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"19.55","vol":"-76.55"},{"date":"2026-06-30","value":"23.12","vol":"-24.55"},{"date":"2026-03-31","value":"11.03","vol":"-20.93"},{"date":"2025-12-31","value":"36.02","vol":"-33.44"},{"date":"2025-09-30","value":"9.69","vol":"-15.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
19.55 | 23.12 | 11.03 | 36.02 | 9.69 |
| 行业(%) | -76.55 | -24.55 | -20.93 | -33.44 | -15.21 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 34/243 ， 46/243。
[{"date":"2026-09-30","value":"0.33","vol":"0.26"},{"date":"2026-06-30","value":"0.22","vol":"0.17"},{"date":"2026-03-31","value":"0.10","vol":"0.08"},{"date":"2025-12-31","value":"0.49","vol":"0.35"},{"date":"2025-09-30","value":"0.35","vol":"0.25"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.33 | 0.22 | 0.10 | 0.49 | 0.35 |
| 行业(次) | 0.26 | 0.17 | 0.08 | 0.35 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.85","vol":"1.68"},{"date":"2026-06-30","value":"1.24","vol":"1.12"},{"date":"2026-03-31","value":"0.60","vol":"0.55"},{"date":"2025-12-31","value":"2.76","vol":"2.33"},{"date":"2025-09-30","value":"1.85","vol":"1.66"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.85 | 1.24 | 0.60 | 2.76 | 1.85 |
| 行业(次) | 1.68 | 1.12 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"24.58","vol":"12.33"},{"date":"2026-06-30","value":"21.45","vol":"14.81"},{"date":"2026-03-31","value":"25.46","vol":"-0.33"},{"date":"2025-12-31","value":"28.08","vol":"32.14"},{"date":"2025-09-30","value":"20.20","vol":"14.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 24.58 | 21.45 | 25.46 | 28.08 | 20.20 |
| 行业 | 12.33 | 14.81 | -0.33 | 32.14 | 14.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"1.34","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.80","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.34 | - | 1.80 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.62 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 58/243 ， 65/243。
[{"date":"2026-09-30","value":"3.47","vol":"5.51"},{"date":"2026-06-30","value":"3.17","vol":"5.78"},{"date":"2026-03-31","value":"3.44","vol":"6.17"},{"date":"2025-12-31","value":"3.20","vol":"5.27"},{"date":"2025-09-30","value":"5.00","vol":"5.64"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.47 | 3.17 | 3.44 | 3.20 | 5.00 |
| 行业 | 5.51 | 5.78 | 6.17 | 5.27 | 5.64 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.71","vol":"4.40"},{"date":"2026-06-30","value":"2.47","vol":"4.71"},{"date":"2026-03-31","value":"2.70","vol":"5.04"},{"date":"2025-12-31","value":"2.54","vol":"4.13"},{"date":"2025-09-30","value":"4.25","vol":"4.49"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.71 | 2.47 | 2.70 | 2.54 | 4.25 |
| 行业 | 4.40 | 4.71 | 5.04 | 4.13 | 4.49 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/243 ， 30/243。
[{"date":"2026-09-30","value":"27.05","vol":"23.57"},{"date":"2026-06-30","value":"28.30","vol":"23.17"},{"date":"2026-03-31","value":"27.48","vol":"22.26"},{"date":"2025-12-31","value":"28.13","vol":"23.19"},{"date":"2025-09-30","value":"26.94","vol":"22.23"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
27.05 | 28.30 | 27.48 | 28.13 | 26.94 |
| 行业(%) | 23.57 | 23.17 | 22.26 | 23.19 | 22.23 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.47","vol":"0.43"},{"date":"2026-06-30","value":"0.50","vol":"0.42"},{"date":"2026-03-31","value":"0.47","vol":"0.40"},{"date":"2025-12-31","value":"0.49","vol":"0.41"},{"date":"2025-09-30","value":"0.45","vol":"0.72"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.47 | 0.50 | 0.47 | 0.49 | 0.45 |
| 行业(%) | 0.43 | 0.42 | 0.40 | 0.41 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 光大证券 | 2026-10-30 | 增持 | 增持 |
| 华源证券 | 2026-09-16 | 买入 | |
| 国盛证券 | 2026-09-07 | 买入 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"0.98","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.13","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.54","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"2.31","blueLineValue":"0.88","type":"YC"}]